Key facts
- Notable investors include Zhongguancun Development Venture Capital Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for MedGencell
- ·The full record, as it builds
Funding rounds
No funding rounds for MedGencell are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MedGencell
Developer of cell medicine designed for medical technology. The company's products mainly focus on cell drug R&D and technical services, which include genome editing and epigenetic modification, rapid in vitro amplification, rapid in vitro evaluation of cell drugs, non-viral transfection, etc., providing customers with reliable and innovative products.
- Sector
- Healthcare
- HQ
- Chengdu, China
- Founded
- 2015
- Employees
- 14
- Website
- en.medgencell.com/
- Ownership
- Privately Held (backing)
MedGencell doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MedGencell shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MedGencell in its N-PORT filings yet. We sweep new filings monthly.